Skip to main content
HR 5776 115th Congress House Health Alternative treatments Congressional oversight Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Government information and archives Government studies and investigations Health care costs and insurance Health care coverage and access Health facilities and institutions Health personnel Health programs administration and funding Health technology, devices, supplies Home and outpatient care Hospital care Medical tests and diagnostic methods Medicare Mental health Rural conditions and development

MOST Act

Introduced: May 11, 2018 Introduced by: Neal, Richard E. Democratic · Massachusetts See on congress.gov
 Everywhere this bill has been 6 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 19, 2018
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-764, Part I.
May 31, 2018
Referred to the Subcommittee on Health.
May 16, 2018
Ordered to be Reported (Amended) by Voice Vote.
May 16, 2018
Committee Consideration and Mark-up Session Held.
May 11, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 11, 2018
Introduced in House
 Plain-English summary Congressional Research Service

Medicare and Opioid Safe Treatment Act or the MOST Act

This bill establishes several requirements for the Centers for Medicare & Medicaid Services (CMS), and alters requirements under Medicare and Medicare Advantage, related to pain management and opioid use.

For example, the bill requires certified opioid treatment program services to be covered under Medicare.

Additionally, among other requirements, the CMS must review payments under Medicare for opioid and non-opioid pain management procedures, specifically with respect to ambulatory outpatient surgical procedures and hospital outpatient department services. The CMS must ensure that there are no payment incentives for using opioids instead of non-opioid alternatives and must make revisions accordingly.

The bill also requires payment under Medicare to federally qualified health centers and rural health clinics that have health care practitioners who are newly certified to provide medication-assisted treatment (e.g., buprenorphine).

What's happening now June 19, 2018

Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-764, Part I.

 Committees of jurisdiction 3